Intestinal Trefoil Factor 3 : a new biological factor mediating gut-kidney crosstalk in diabetic kidney disease
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
PURPOSE: To investigate the effect of TFF3 in the pathogenesis of Diabetic Kidney Disease (DKD), and explore the dynamic changes of TFF3 expression pattern in renal injury process.
METHODS: DKD animal model was established by streptozotocin (STZ) (40 mg/kg/d, ip, for 5 days, consecutively) combined with the high fat diet (HFD) for 12 weeks. While animals were sacrificed at different time stages in DKD process (4 weeks, 8 weeks and 12 weeks, respectively).
RESULTS: STZ combined with high-fat diet induced weight gain, increased blood glucose and decreased glucose tolerance in DKD mice. Compared to the control group, the DKD group exhibits extracellular matrix (ECM) accumulation and the renal injury was aggravated in a time-dependent manner. The TFF3 expression level was decreased in kidney, and increased in colon tissue.
CONCLUSION: TFF3 is not only expressed in colon, but also expressed in renal medulla and cortex. TFF3 might be play a pivotal role in renal mucosal repair by gut-kidney crosstalk, and protect renal from high glucose microenvironment damage.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
---|---|
Enthalten in: |
Endocrine - 84(2024), 1 vom: 01. Apr., Seite 109-118 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Tao [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biological Factors |
---|
Anmerkungen: |
Date Completed 04.04.2024 Date Revised 04.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s12020-023-03559-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366390961 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM366390961 | ||
003 | DE-627 | ||
005 | 20240404234523.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s12020-023-03559-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n1364.xml |
035 | |a (DE-627)NLM366390961 | ||
035 | |a (NLM)38148440 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Tao |e verfasserin |4 aut | |
245 | 1 | 0 | |a Intestinal Trefoil Factor 3 |b a new biological factor mediating gut-kidney crosstalk in diabetic kidney disease |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.04.2024 | ||
500 | |a Date Revised 04.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a PURPOSE: To investigate the effect of TFF3 in the pathogenesis of Diabetic Kidney Disease (DKD), and explore the dynamic changes of TFF3 expression pattern in renal injury process | ||
520 | |a METHODS: DKD animal model was established by streptozotocin (STZ) (40 mg/kg/d, ip, for 5 days, consecutively) combined with the high fat diet (HFD) for 12 weeks. While animals were sacrificed at different time stages in DKD process (4 weeks, 8 weeks and 12 weeks, respectively) | ||
520 | |a RESULTS: STZ combined with high-fat diet induced weight gain, increased blood glucose and decreased glucose tolerance in DKD mice. Compared to the control group, the DKD group exhibits extracellular matrix (ECM) accumulation and the renal injury was aggravated in a time-dependent manner. The TFF3 expression level was decreased in kidney, and increased in colon tissue | ||
520 | |a CONCLUSION: TFF3 is not only expressed in colon, but also expressed in renal medulla and cortex. TFF3 might be play a pivotal role in renal mucosal repair by gut-kidney crosstalk, and protect renal from high glucose microenvironment damage | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Biological markers | |
650 | 4 | |a DKD | |
650 | 4 | |a Gut-kidney axis | |
650 | 4 | |a Trefoil factor 3 | |
650 | 4 | |a Type 2 diabetes mellitus | |
650 | 7 | |a Trefoil Factor-3 |2 NLM | |
650 | 7 | |a Biological Factors |2 NLM | |
650 | 7 | |a Glucose |2 NLM | |
650 | 7 | |a IY9XDZ35W2 |2 NLM | |
700 | 1 | |a Zhang, Yinghui |e verfasserin |4 aut | |
700 | 1 | |a Tao, Jie |e verfasserin |4 aut | |
700 | 1 | |a Rong, Xianglu |e verfasserin |4 aut | |
700 | 1 | |a Yang, Yiqi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Endocrine |d 1995 |g 84(2024), 1 vom: 01. Apr., Seite 109-118 |w (DE-627)NLM091795540 |x 1559-0100 |7 nnns |
773 | 1 | 8 | |g volume:84 |g year:2024 |g number:1 |g day:01 |g month:04 |g pages:109-118 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12020-023-03559-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 84 |j 2024 |e 1 |b 01 |c 04 |h 109-118 |